Sarepta Wins Exclusive License, Collaboration Deal for European Rights To Summit's DMD Drug
October 04, 2016 at 08:37 AM EDT
Sarepta Therapeutics Inc (NASDAQ: SRPT) and Summit Therapeutics plc (NASDAQ: SMMT) reached an exclusive license and collaboration ...